Page 103 - Mesenchymal Stem cells, Exosomes and vitamins in the fight aginst COVID

Pain Physician: August 2020 COVID-19 Special Issue 23:S391-S420

cells for alcoholic cirrhosis: Phase 2 et al. Remdesivir for the treatment of
trial. Hepatology 2016; 64:2185-2197. Covid-19-Preliminary report. N Engl term engraftment and no ectopic
59. Bai YQ, Yang YX, Yang YG, et al. J Med 2020 May 22. [Epub ahead of tissue formation. Stem Cells 2012;
30:1575-1578.
Outcomes of autologous bone marrow print].
mononuclear cell transplantation in 68. Hernigou P, Auregan JC, Dubory A, 76. Turner L. Preying on public fears and
decompensated liver cirrhosis. World Flouzat-Lachaniette CH, Chevallier anxieties in a pandemic: Businesses
Journal of Gastroenterology: WJG 2014; N, Rouard H. Subchondral stem cell selling unproven and unlicensed
20:8660-8666. therapy versus contralateral total “Stem Cell Treatments” for COVID-19.
Cell Stem Cell 2020; 26:806-810.
60. am Esch JS 2nd, Knoefel WT, Klein M, knee arthroplasty for osteoarthritis
et al. Portal application of autologous following secondary osteonecrosis of 77. CISON PR Newswire. Panel of
CD133+ bone marrow cells to the the knee. Int Orthop 2018; 42:2563-2571. noted academics and stem cell
liver: A novel concept to support 69. Sanapati J, Manchikanti L, Atluri S, et experts conclude Delphi panel to
hepatic regeneration. Stem Cells 2005; al. Do regenerative medicine therapies protect patients. Available at: www.
23:463-470. provide long-term relief in chronic prnewswire.com/news-releases/
61. Kim JK, Kim SJ, Kim Y, et al. Long- low back pain: A systematic review panel-of-noted-academics-and-stem-
cell-experts-conclude-delphi-panel-
term follow-up of patients after and metaanalysis. Pain Physician 2018; to-protect-patients-300933490.html.
autologous bone marrow cell infusion 21:515-540. Accessed May 18, 2020.
for decompensated liver cirrhosis. Cell 70. Manchikanti L, Centeno CJ, Atluri S,
Transplantation 2017; 26:1059-1066. et al. Bone marrow concentrate (BMC) 78. Lieber P. When it comes to the use of
62. Li YH, Xu Y, Wu HM, Yang J, et al. therapy in musculoskeletal disorders: stem cells for osteoarthritis- Do your
due diligence. Am Acad Assoc Orthop
Umbilical cord-derived mesenchymal Evidence-based policy position Med. Available at: www.aaomed.
stem cell transplantation in hepatitis statement of American Society of org/aaomed/files/cclibraryfiles/
B virus related acute-on-chronic liver Interventional Pain Physicians (ASIPP). filename/000000000887/ARTICLE_
failure treated with plasma exchange Pain Physician 2020; 23:E85-E131. WHEN%20IT%20COMES%20
and entecavir: A 24-month prospective 71. Manchikanti L, Sanapati J, Benyamin TO%20STEM%20CELLS%20DO%20
study. Stem Cell Reviews and Reports RM, Atluri S, Kaye AD, Hirsch JA. YOUR%20DUE%20DILIGENCE_
2016; 12:645-653. Reframing the prevention strategies LIEBER.pdf. Accessed May 20, 2020.
63. Lin BL, Chen JF, Qiu WH, et al. of the opioid crisis: Focusing on 79. Navani A, Manchikanti L, Albers SL,
Allogeneic bone marrow-derived prescription opioids, fentanyl, and et al. Responsible, safe, and effective
mesenchymal stromal cells for heroin epidemic. Pain Physician 2018; use of biologics in the management
hepatitis B virus-related acute-on- 21:309-326. of low back pain: American Society of
chronic liver failure: A randomized 72. Atluri S, Manchikanti L, Hirsch Interventional Pain Physicians (ASIPP)
controlled trial. Hepatology 2017; JA. Expanded umbilical cord Guidelines. Pain Physician 2019;
66:209-219. mesenchymal stem cells (UC-MSCs) 22:S1-S74.
64. Tsang KS, Ng CPS, Zhu XL, et al. as a therapeutic strategy in managing 80. Bauer G, Elsallab M, Abou-El-Enein
Phase I/II randomized controlled trial critically Ill COVID-19 patients: The M. Concise review: A comprehensive
of autologous bone marrow-derived case for compassionate use. Pain analysis of reported adverse events in
mesenchymal stem cell therapy for Physician 2020; 23:E71-E83. patients receiving unproven stem cell-
chronic stroke. World J Stem Cells 2017; 73. Musial-Wysocka A, Kot M, Majka M. based interventions. Stem Cells Transl
9:133-143. The pros and cons of mesenchymal Med 2018; 7:676-685.
65. Sengupta V, Sengupta S, Lazo A stem cell-based therapies. Cell 81. The New York Times. 12 People
Jr, Woods P, Nolan A, Bremer N. Transplant 2019; 28:801-812. hospitalized with infections from stem
Exosomes derived from bone marrow 74. Lalu MM, McIntyre L, Pugliese C, cell shots. Available at: www.nytimes.
mesenchymal stem cells as treatment et al. Safety of cell therapy with com/2018/12/20/health/stem-cell-
for severe COVID-19. Stem Cells Dev mesenchymal stromal cells (SafeCell): shots-bacteria-fda.html. Accessed May
2020; 29:747-754. A systematic review and meta-analysis 18, 2020.
66. Liang B, Chen J, Li T, et al. Clinical of clinical trials. PLoS One 2012; 82. www.cdc.gov/hai/outbreaks/stem-cell-
remission of a critically ill COVID-19 7:e47559. products.html. Accessed May 17, 2020.
patient treated by human umbilical 75. von Bahr L, Batsis I, Moll G, et
cord mesenchymal stem cells. al. Analysis of tissues following
ChinaXiv 2020; 1-13. mesenchymal stromal cell therapy
67. Beigel JH, Tomashek KM, Dodd LE, in humans indicates limited long-

S420 www.painphysicianjournal.com